Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics

计划入组 10 人 · 首次发布于 2021 年 9 月 28 日

The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study

计划入组 10 人 · 首次发布于 2021 年 3 月 26 日

Sodium Glucose Cotransporter-2 Inhibitors and Salt-sensitivity in Type 2 Diabetes

计划入组 30 人 · 首次发布于 2023 年 8 月 23 日

CPL-200-075

SGLT-2 inhibitors (type 2 diabetes)

2-deoxy-2-fluoro-α-D-glucose

C₆H₁₁FO₅

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

RIVER 2 RENAL CORP.

United States

SGLT-2 Inhibitors Linked to Reduced Dementia Risk in Type 2 Diabetes Study

SGLT-2 Inhibitors Linked to Reduced Dementia and Parkinson's Risk in Type 2 Diabetes Patients

SGLT-2 Inhibitors Show 11% Reduction in Autoimmune Disease Risk in Large Korean Study